A comparison of polychemotherapy and melphalan/prednisone for primary remission induction, and interferon-alpha for maintenance treatment, in multiple myeloma. A prospective trial of the German Myeloma Treatment Group
- 31 December 1995
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (2) , 146-151
- https://doi.org/10.1016/0959-8049(94)00452-b
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The Treatment of Multiple MyelomaNew England Journal of Medicine, 1994
- Multiparameter analyses of normal and malignant human plasma cells: CD38++, CD56+, CD54+, cIg+ is the common phenotype of myeloma cellsAnnals of Hematology, 1992
- Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: an overview of published trials.Journal of Clinical Oncology, 1992
- Effective natural interferon-alpha therapy in recombinant interferon- alpha-resistant patients with hairy cell leukemiaBlood, 1991
- Interferons in the treatment of multiple myeloma.Journal of Clinical Oncology, 1990
- Induction and maintenance therapy in multiple myeloma: a multicenter trial of MP versus VCMPEuropean Journal of Cancer and Clinical Oncology, 1988
- Histologic Classification and Staging of Multiple Myeloma: A Retrospective and Prospective Study of 674 CasesAmerican Journal of Clinical Pathology, 1987
- Smoldering Multiple MyelomaNew England Journal of Medicine, 1980
- Multiple myeloma: quantitative staging and assessment of response with a programmable pocket calculatorBlood, 1977
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975